• Dosing for Lexaria’s ambitious and most comprehensive clinical study, HYPER-H21-4, was successfully completed in July 2022, with newly analyzed results now emerging
• Its latest findings bring the company closer to its upcoming FDA Phase 1b study while also explaining the patented DehydraTECH-(TM)-processed CBD interaction with the sympatho-chromaffin system via catestatin modulation
• Lexaria’s management is optimistic that DehyraTECH-CBD and its effectiveness in modulating catestatin levels could become a significant value enhancer should it eventually enter the marketplace as an approved hypertension treatment

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, kicked off its human clinical study, HYPER-H21-1 in 2021, focused on testing its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) for the potential use as a hypertension treatment alternative (https://ibn.fm/hdVQ9). On July 27, 2022, the company announced that the dosing for its HYPER-H21-4 multi-week human clinical study was successfully completed, with no serious adverse events resulting from the dosing (https://ibn.fm/IZTUN).

This safety-related outcome – no serious adverse events – is generally speaking the desired primary outcome of Lexaria’s upcoming Phase 1b FDA-registered study.

Designed to enhance Lexaria’s probability of success toward an Investigational New Drug (“IND”) application filing for the U.S. Food and Drug Administration (“FDA”) approval, HYPER-H21-4 was the most comprehensive clinical study ever undertaken by Lexaria, with many types of analysis performed. Its latest findings from the study take things a step further while also explaining DehydraTECH-CBD’s interaction with the sympatho-chromaffin system via catestatin modulation.

In addition, the findings have been published in the respected peer-reviewed journal, “Biomedicine and Pharmacotherapy.” The company is aware of only a handful of other published research studies that have investigated whether a sustained decrease in resting blood pressure (“BP”) is possible following multiple weeks of oral CBD dosing, none of which have been successful in achieving this (https://ibn.fm/qPQYM).

The findings showed that DehydraTECH-CBD resulted in a statistically significant reduction in average baseline serum catestatin concentrations of 13.50 ng/mL to just 9.65 ng/mL after five weeks of dosing, representing a 28.5% drop. In addition, mean arterial pressure significantly dropped by 4.26 ± 1.26 mm/Hg following the five weeks of DehydraTECH-CBD dosing. No statistically significant reductions in catestatin concentrations were identified in the placebo group.

Given the growing demand for alternative anti-hypertensive treatments and therapies, Lexaria recognizes an opportunity and seeks to fill it. These latest results from its ambitious HYPER-H21-4 study inch the company closer to achieving that goal, ultimately becoming a leader and tapping into a pharmaceutical market that is set to be valued at $34 billion by 2030. Lexaria’s management is optimistic that DehydraTECH-CBD and its effectiveness in modulating catestatin levels could become a significant value enhancer should it eventually enter the marketplace as an approved hypertension treatment.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• A fast-moving ransomware strike recently infected servers made by California-based cloud computing giant, VMWare, leveraging known vulnerabilities previously disclosed by this software company
• Ransomware continues to be one of the top digital threats and the problem is exacerbated by poor cybersecurity practices, such as lapses in adequate vulnerability management
• The attack is the last in a series of reminders that businesses need reliable cybersecurity systems and practices provided by companies like Data443 Risk Mitigation to combat malicious attacks instigated by cybercrime perpetrators

Cybercriminals are striking again, reminding the public that they are quick to detect and take advantage of any vulnerabilities left uncovered. A large ransomware campaign has been launched recently to target VMware ESXi hypervisors worldwide, potentially compromising around 3,800 vulnerable servers globally (https://ibn.fm/NaXEk). In what seems to be a wave of attacks, cybercriminals appear to be exploiting a heap overflow vulnerability with an “important” severity rating to access vulnerable servers. As a result, ransomware alerts spread like wildfire worldwide, ushering thousands of companies to perform urgent system scans as they rushed to detect any signs of compromise. Events like this remind us that cyber perpetrators are on the constant lookout for businesses’ blind spots that suffer from sloppy cybersecurity practices. With a mission focused on preventing cyber incidents like this, Data443 Risk Mitigation (OTC: ATDS) remains committed to supporting business-critical data in flight and at rest, while meeting the growing need for data discovery, governance, and protection services.

Over the past years, cybersecurity has become much more than a buzzword – it has become a necessity. In the wake of cyberattacks that grow in frequency and scale, cybersecurity serves as the wall keeping criminals from compromising sensitive data and taking down networks or systems which disrupt normal operations. Companies that don’t have adequate cyber protection systems are exposed to a massive threat that can ruin their relationships with customers, employees, and other stakeholders and expose businesses to considerable legal risk. VMware, a California-based cloud computing giant that produced the affected servers, publicly released patches for this vulnerability two years ago. Still, as it turns out, there are many businesses that have not yet applied the patch and thus left themselves open to this malicious attack. This latest strike goes to show that cyber security hygiene is vital for preventing ransomware attacks.

In today’s world, where more and more business and personal lives are online, cyberattacks are considered the world’s fastest-growing crime. As new digital devices become ubiquitous and we grow reliant on emerging digital technologies, including self-driving cars, and smart home security systems, we continue to be increasingly vulnerable to cybercrime threats as criminals find new ways to steal and abuse that data for their financial gain.

In the latest report, the FBI’s Internet Crime Complaint Center revealed that it received 847,376 complaints regarding cyberattacks and malicious cyber activity that caused almost $7 billion in losses in 2021. Moreover, the losses from hacking incidents skyrocketed at the rate of 64% year over year. Therefore, it is no surprise that the global cybersecurity market is expected to snowball with a projected CAGR of 12.8% from 2022 to 2030, generating USD 657.02 billion by the end of that period (https://ibn.fm/JZEiF). And nowadays, it appears that no business is safe from malicious cyber activity. As more and more large corporations invest in cybersecurity infrastructure, criminals are increasingly targeting small and medium-sized companies, which tend to have less resilient cyber protection (https://ibn.fm/IEkMG).

In a heated environment like this, where criminals are quick to adapt and take advantage of exposed vulnerabilities, Data443 Risk Mitigation has emerged as a critical player within the cyber security space with an extensive product suite and comprehensive toolset designed to help companies securely manage data on-premises, in the cloud and in hybrid environments. The Company helps customers prioritize risk, detect security gaps, and implement adequate data protection and privacy management procedures by providing a comprehensive range of products and services, including data archiving, file sharing, ransomware recovery and access control to sensitive content management and global privacy management.

Strategically positioned to benefit from the growing demand for data protection as technologies and practices designed to keep systems and digital data safe are becoming top of mind for companies around the world, Data443 Risk Mitigation is poised to expand its product reach to include some of the world’s largest organizations. With more than 10,000 customers across 100 countries, the Company boasts an impressive lineup of clients, including a Fortune 500 Fintech, a major U.S. energy provider, and a leading global investment bank headquartered in New York City.

Data443 Risk Mitigation, Inc. (ATDS) Investor Relations Matthew Abenante ir@data443.com 919-858-6542

For more information, visit the company’s website at https://data443.com/.

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

• B2B marketplace builder Freight Technologies Inc. is an innovator in resources for strengthening commercial supply chain transports between the United States, Canada and Mexico
• Freight Technologies, also known as Fr8Tech, has developed its AI-powered Fr8App resource to provide shippers and carriers with the tools they need for monitoring shipments and vehicle performance, and improving efficiency
• In this month’s State of the Union address, President Joe Biden restated his administration’s commitment to boosting manufacturing close to home through policies that sustain price competitiveness and respect for quality employment
• Amid optimism for U.S. trade and labor policies, Fr8Tech recently announced revenue projections for 2023, boosting its anticipated sales by 40 percent to between $36 million and $42 million

Over-the-road shipping technology innovator Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is dedicated to keeping freight moving around the country and between the United States’ primary land-based trading partners in an efficiently designed and successful manner, using the company’s flagship AI-powered Fr8App B2B marketplace as a powerful tool.

Freight Technologies (also stylized as Fr8Tech) recently announced its market guidance data for the coming year, projecting revenues of between $36 million and $42 million for 2023, which will be an increase over 2022’s preliminary revenue figures of approximately $26 million to $27 million (https://ibn.fm/jUZxK).

The company’s projections for revenue growth are underscored by the comments President Joe Biden made during the White House’s annual State of the Union address earlier this month, restating the administration’s goals of promoting made-in-America projects despite continued strong impetus in the business sector for trading with foreign economies, particularly market-dominant imports ($537 billion in 2022) from China (https://ibn.fm/lmq0G).

While much of the U.S. trade policy focus has been on tensions with China and Russia, Canada and Mexico remain the America’s largest two-way trading partners — with $794 billion and $779 billion transacted last year between the countries, respectively, reflecting the lengthy land borders the nations share with the United States and a recently updated three-way free trade agreement, according to new U.S. Commerce Department data (https://ibn.fm/jQ7yl).

Commercial truck transport is a key element of the land-based trade closest to home undergirding administration shipping policies both for domestic manufacture and partners in the United States-Mexico-Canada Agreement (“USMCA”), which replaced the North America Free Trade Agreement (“NAFTA”) in 2020 as a mutually beneficial trade strategy for North American workers, farmers, ranchers, and businesses (https://ibn.fm/IE4xe).

Freight Technologies’ Fr8App fleet tracking solution helps smaller carriers compete with big retailers by enabling business owners and fleet managers to monitor and manage transport vehicles, identifying the progress of shipments, reducing fuel costs, ensuring greater driver safety, and helping drivers fulfill maintenance needs (https://ibn.fm/2ARNC).

“We look forward to continued growth in our cross-border and domestic FTL offerings over the course of the next 12 to 24 months and come into 2023 with a strong pipeline of existing customers and new prospects and growing lines of business,” Fr8Tech CEO Javier Selgas stated in the company’s revenue announcement. “We are revising our guidance for 2023 revenues to be in the $36 to $42 million range as we continue to invest in our technology and are capturing early returns from our new product offerings.”

For more information, visit the company’s website at www.Fr8Technologies.com.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications IBN (InvestorBrandNetwork) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com

The Web3 Toronto Summit, which will be held from March 1-2, 2023, invites entrepreneurs, investors, professionals, collaborators, and enthusiasts of the Metaverse, blockchain and Web3 spectrum, to participate in a robust networking and business opportunity for the Web3 community in Canada and beyond.

With Web3 and other evolving technologies growing by leaps and bounds, the Web 3 Toronto Summit will serve as a meaningful initiative of uniting these industries at a common forum. Enthusiasts, traders, and entrepreneurs from all over the world will gather for an unforgettable opportunity of learning and networking through immersive events, experiences, parties, conferences, pitching rooms, workshops, entertainment, and more.

The agenda of organizers at Web3 Toronto is to provide a platform for learning and education about blockchain technology. WEB3 Toronto is organized by the team of DX3 USA and DX3 Canada, focused on delivering valuable content about technology in the retail and marketing industry. They aim to offer a robust platform for experts and learners to improve their understanding of NFT, Blockchain, and the Metaverse. The event is co-located with DX3 Canada 2023 at Toronto Conference Centre. Registrations are ongoing for interested attendees.

Web3 Toronto aims at:

• Give The Community A Voice: Bring to the forefront speakers to provide a forum for the NFT community to give voice to most relevant ideas of the moment.
• Connection: Offer a common platform to people who are working on like projects.
• Promote: Provide knowledge and guidance to the global community about the value of NFTs.

The Web3 Toronto Summit will be attended by the stalwarts of emerging technologies who will impart their valuable insights and ideas to the attending audience. Connect with the influencers and experts of these emerging industries who will cover topics about blockchain, Web3 and digital assets, to name a few. Attendees can participate in discussions and panels conducted by industry leaders who will discuss the latest trends in technology. Learn and get access to educational content involving innovation and market insights for expanding your business.

Along with DX3, the Web3 Toronto event is organized by IOT Intelligent Cities, a public sector event comprising various summits, interactive workshops, exhibitors showcasing various products and lots of networking opportunities. Hifazat ‘Faz’ Ahmad, President, of IoT Events, is an experienced business leader who delivers growth by helping transform struggling businesses into development-oriented enterprises.

To learn more, please visit (https://ibn.fm/6QHIE).

• The Department of Energy recently agreed on a $74 million funding initiative aimed at 7 pilot projects exploring different methods of harnessing geothermal energy
• Geothermal energy currently generates 3.7 billion kilowatts per annum of electricity in the United States – enough to power 2.5 million homes
• GeoSolar Technologies has been an early mover within the geothermal technology space, using the renewable energy source as the foundation of its revolutionary SmartGreen(TM) Home system

Around 2,900 kilometers (1,800 miles) beneath the Earth’s surface lies the hottest part of our planet – the core. A small portion of the core’s heat, which can rise to over 5,000 degrees Celsius or 9,000 degrees Fahrenheit, is delivered from the friction and gravitational pull which results from the Earth’s creation over 4 billion years ago; however, most of the Earth’s heat is generated through the constant decay of radioactive isotopes, namely postassium-40 and thorium-232. Harnessing the heat generated by the Earth’s core, a process called geothermal energy, is still in its relative infancy; in the United States today, geothermal energy currently generates about 3.7 billion kilowatt hours of electricity per year – enough to power over 2.5 million homes. However, that pales in comparison to more conventional fossil fuels; coal alone accounted for 898 billion kilowatt hours of electricity in the U.S. as of 2021 (https://ibn.fm/Ues2C). That figure may now be poised to change.

In early February 2023, the U.S. Department of Energy (“DOE”) announced a funding opportunity of up to $74 million for seven pilot projects which would individually seek to test the efficacy and scalability of enhanced geothermal systems (“EGS”). Forming part of the landmark Bipartisan Infrastructure Law (“BIL”), the pilot projects to use innovative technology and a variety of development techniques to capture the Earth’s abundant heat sources in diverse geologic settings. Moreover, and through this investment, the DOE hopes that research from the findings will prove a justifiable case for the potential for geothermal energy to provide reliable, around-the-clock electricity to tens of millions of homes across the country (https://ibn.fm/rx1SW).

What is unique about geothermal energy, is the basis by which it forms. Recent findings from the University of California Berkeley discovered that the Earth’s core may contain as much as 1,200 parts per million of potassium-40, or just over one tenth of one percent of the core’s entire mass.

“This amount may seem small and is comparable to the concentration of radioactive potassium naturally present in bananas. Combined over the entire mass of the Earth’s core, however, it can be enough to provide one-fifth of the heat given off by the Earth,” stated Kanani Lee, a Ph.D. researcher at UC Berkeley (https://ibn.fm/MyO5M).

As potassium-40 decays, its nucleus changes, emitting enormous amounts of energy and radiation. Heat from the Earth’s core radiates outwards, warming rocks, water, gas and other geological material on the way; studies have shown that the heat dissipated in temperature by approximately 25 Celsius per 1 kilometer of depth (1 degree Fahrenheit per 77 feet). Whilst in some areas of the world such as Iceland, abundant sources of hot, easily accessible underground reservoirs of water make it possible to rely on geothermal sources as a safe, dependable, and inexpensive source of energy, the process to harness geothermal energy in the United States is somewhat different (https://ibn.fm/neDZT).

GeoSolar Technologies (“GST”), a Colorado-based climate technology Company pioneering an approach into clean energy solutions for households, has been an early mover within geothermal energy in the United States. Through the introduction of its proprietary SmartGreen(TM) Home system – an environmentally friendly, renewable energy focused technology designed to harness energy from the Earth and sun to power and purify homes and automobiles without the use of fossil fuels, GeoSolar have looked to tackle the astounding thirty percent of global greenhouse gases generated by households every year.

The heart of the SmartGreen(TM) Home system lays within geothermal ground-based energy beneath the average home. Through a truck-mounted or modular sonic rig, GeoSolar seeks to drill 4–6-inch wells down 300-400 feet below the surface, subsequently inserting high-density polyethylene pipe ground loops that can tap into the unlimited source of geothermal energy available. The ground loops operate the geothermal system function by constantly circulating non-toxic fluid to a high-volume heat/air pump. The heat pump and circulating fluid continuously transfers heat from the home into or out of the ground depending on the season. Moreover, the system can be easily connected to existing air ducts or radiant flooring loops, thereby accounting for all of the home’s heating, cooling and hot water requirements.

Historically, the key barriers towards greater geothermal energy adoption lays within the financial sphere. Geothermal power plant suffers from much higher capital costs (and therefore, slower payback periods) relative to other forms of renewable energy. Moreover, existing techniques for placing wells at traditional hydrothermal sites have been largely unsuccessful, with many wells failing to produce enough to go into use – variables which have detrimentally affected incremental investment within the technology. As a result, the largest geothermal steam electricity plant in the United States, located in California, was built as far back as September 1960 (https://ibn.fm/0KQFz). With its most recent funding endeavors, the DOE hopes to change this paradigm. GeoSolar Technologies for one, stand to benefit from the ongoing shift in the United States’ renewable energy mix.

For more information, visit the company’s website at www.GeoSolarPlus.com.

NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• BiondVax is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products
• The company primarily targets infectious diseases and autoimmune diseases, with its lead candidate, an inhaled COVID-19 NanoAb therapy, the subject of preclinical studies
• So far, the preclinical studies have shown that the NanoAb results in significantly milder illness and faster recovery, eliminates the SARS-CoV-2 virus from the lungs, and prevents illness when administered prophylactically
• The FDA has revoked the authorization of multiple mAb treatments and one mAb prophylactic drug, creating a significant gap in a market that has shown strong demand for COVID-19 treatments
• BiondVax is uniquely positioned to meet this demand, backed by an extensive library of NanoAbs that allows it to rapidly develop neutralizing treatment as soon as a new variant emerges

The Food and Drug Administration (“FDA”) has, over the last two years, authorized several drugs as treatments for mild-to-moderate COVID-19 or as pre-exposure prophylaxis (“PrEP”) for the prevention of the disease. Most of these drugs were based on human monoclonal antibody (“mAb”) technology and were designed to boost the immune system by mimicking natural neutralizing antibodies. The mAbs would bind with the SARS-CoV-2 virus’ receptor binding domain, a section of the viral spike protein, preventing it from entering the patient’s cells and exacerbating the infection.

However, the virus has continually mutated as it works to correct ‘flaws’ that make it vulnerable to treatment. This has rendered previously authorized mAb treatments ineffective, with the FDA progressively revoking authorizations for these therapies as a result. For example, in November last year, the agency deauthorized bebtelovimab, the last of the COVID-19 treatment antibodies. And in January, a similar fate befell AstraZeneca PLC (NASDAQ: AZN)’s Evusheld, which was designed as a PrEP treatment (https://ibn.fm/OBKpX), and in the first nine months of 2022 generated $1.5 billion in sales, a testament to the huge demand for proactive COVID protection.

Although other non-monoclonal-antibody therapies remain authorized, none can be administered as PrEP for the prevention the COVID-19 disease, according to the FDA’s Emergency Use Authorization webpage (https://ibn.fm/41gyW). Furthermore, Pfizer Inc. (NYSE: PFE)’s Paxlovid, which is still effective against the new subvariants of the Omicron variant, has multiple contraindications for common drugs including blood thinners, heart medications, and prescribed statins. Those patients who were ineligible to receive Paxlovid would have previously received mAb-based drugs. But this is no longer the case.

“Encouragingly,” Amir Reichman, CEO of biotechnology company BiondVax Pharmaceuticals (NASDAQ: BVXV), wrote in his letter to shareholders published December 30, 2022 (https://ibn.fm/b62Lh), “our lead NanoAb candidate, currently being prepared for clinical trials, has demonstrated neutralization of all relevant Omicron subvariants.”

Reichman was highlighting one of the outstanding benefits of the company’s alpaca-derived nanosized antibodies (“NanoAbs”), which exhibit potential superior therapeutic capabilities for a wide range of diseases, including COVID-19. BiondVax, which focuses on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has so far shown, through an ongoing in vivo preclinical proof-of-concept study, that its lead NanoAb candidate for the treatment of COVID-19 exhibits significant competitive advantages over existing mAbs and oral therapies.

According to statistically significant results released early January, BiondVax established that its inhaled therapy virtually eliminated the SARS-CoV-2 virus and prevented illness when administered prophylactically. The first set of results, announced January 6, showed that a group of COVID-19-infected hamsters that were treated with the company’s inhaled anti-COVID-19 therapy had over 30x lower lung viral titer on average than the placebo group. These results built on previously announced data, which indicated that the NanoAb treatment led to significantly milder illness and faster recovery compared to the placebo group (https://ibn.fm/MGKRe).

The second set of results, announced January 23, evidenced that when the NanoAb was administered by inhalation three hours before infection, it virtually prevented the hamsters from contracting the illness. In particular, the hamsters that received the inhaled NanoAb experienced no significant weight loss over the six-day trial, while the untreated control groups’ weight reduced by 12% on average (https://ibn.fm/WQZSQ). This data shows the prophylactic capabilities of the NanoAb, positioning the company to fill the huge void left by the withdrawal of Evusheld’s authorization.

BiondVax, which aims to replicate in human trials the efficacy demonstrated so far in its animal studies, believes there will continue to be a strong market demand for COVID prophylactics and treatments. This belief is supported by Pfizer’s recent report (https://ibn.fm/ffSCz), suggesting that revenues from COVID products is expected to grow in 2024. Backed by libraries with millions of COVID-19 NanoAb candidates developed by its collaborators at the Max Planck Institute for Multidisciplinary Sciences (“MPI”) and the University Medical Center Göttingen (“UMG”), BiondVax is well positioned to meet the demand.

“Indeed, the emergence of new variants remains a concern, and NanoAb therapeutics have the potential to quickly and effectively address new variants,” Reichman’s letter continues. “Our collaborators at MPI and UMG have generated libraries, each with ~300 million COVID-19 NanoAb candidates, as compared to mAb libraries that contain only thousands of options. Thus, as new variants emerge, we would expect to be in a position to rapidly develop a new neutralizing NanoAb”.

For more information, visit the company’s website at www.BiondVax.com.

NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV

• D-Wave’s Qubits annual user conference, currently in its seventh year, is one of the industry’s premier quantum computing events differentiated by its focus on real-world applications of quantum technology
• The company displayed its continued commercial customer momentum and real-time product innovation, reflecting the increasing enterprise adoption of quantum computing solutions
• The conference demonstrated how D-Wave’s proprietary technology helps organizations solve highly complex business problems today

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced new and renewed commercial customer engagements and product updates for its annealing and gate-model quantum computing solutions during the company’s annual Qubits 2023 user conference. The company’s continued commercial customer momentum and product innovation reflect the increased adoption of quantum computing solutions and showcase the technology’s ability to solve businesses’ most challenging computational problems today (https://ibn.fm/dRRdr).

The Qubits event, now in its seventh year, is one of the industry’s premier quantum computing events and is differentiated by its focus on the real-world application of quantum technology to today’s business problems. Quantum-hybrid applications on display at Qubits included solutions from: Mastercard (customer loyalty and rewards allocation), Davidson Technologies (missile defense optimization), Recruit Group (TV commercial allocation), Pattison Food Group (grocery operations optimization), SavantX (port operations optimization), and many more. In addition to showcasing commercial quantum applications during the conference, D-Wave announced that it had added several new high profile customers to its portfolio, working on a diverse set of potential use cases. New and renewing commercial customers working with D-Wave on quantum-hybrid use cases include Siemens Healthineers, Unisys, and Davidson Technologies. These companies are exploring various applications that span medical imaging, military defense optimization, and vehicle routing.

In the event keynote, Dr. Alan Baratz, CEO of D-Wave, outlined that practical quantum computing solutions are becoming essential to helping businesses compete, innovate, and grow. “As we gather at our annual Qubits user conference in Miami this week, the commercialization of quantum is on full display. Currently, more than 60 companies are working with us on real-world quantum-hybrid applications that are unlocking business value today,” Dr. Baratz underlined. “Unlike other modalities, annealing quantum computing is commercial-grade and enterprise-ready, and customers are realizing the benefits of this powerful technology now.”

During the conference, D-Wave shared the progress made toward its next-generation Advantage2^TM annealing quantum computing system, expected to feature 7000+ qubits and 20-way connectivity, which will be implemented in a new lower-noise fabrication stack to enable customers to solve incrementally more complex problems with greater precision.

D-Wave also showcased several recent enhancements to its constrained quadratic model (“CQM”) hybrid solver in its Leap cloud service. These include continuous variables that enable better representation of constrained problems, the handling of weighted restraints that allow quantum developers to more easily and accurately model problems, and pre-solve techniques that reduce the size of problems and allow for larger models to be submitted to the hybrid solver.

Other milestones shared by D-Wave during the event covered the scalable qubit design and readout method validation and the company’s gate-model simulator launched in the Ocean suite of open-source tools. “Our relentless and on-time product delivery reflects a deep commitment to ongoing innovation that accelerates quantum computing adoption, usage and customer value,” Dr. Baratz added. “Through the continued development of our quantum annealing and gate model quantum solutions, we’re focused on building and delivering the full breadth of quantum solutions to our customers, both today and into the future, bringing our unique cross-platform vision to life.”

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward-Looking Statements

This article contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this article include, but are not limited to, statements regarding the release and performance of the Advantage2 processor. We cannot assure you that the forward-looking statements in this article will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; customer acceptance of our products and services; and the uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the registration statement on Form S-1 filed by the Company with the SEC on February 13, 2023, as well as factors associated with companies, such as D-Wave, that are engaged in the business of quantum computing, including anticipated trends, growth rates, and challenges in those businesses and in the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; changes in applicable laws and regulations; the effect of pandemics, geopolitical events, natural disasters, wars, or terrorist acts on our business or the economy in general; and the impact of inflation. Furthermore, if the forward-looking statements contained in this article prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not place undue reliance on these statements in making an investment decision or regard these statements as a representation or warranty by any person we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this article represent our views as of the date of this article. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this article.

DX3 is a leading event management enterprise, organizing summits and trade shows that unite retail, marketing, and technology professionals, leaders, and businesses, on a single floor. They strive to bring meaningful and informative content under one roof, offering a learning and networking opportunity to these industries for better expansion and growth.

The experts offer industry insights and gather innovation solutions from international speakers as they conduct discussions, workshops, and meetings at the DX3 Canada 2023 Summit. Be a part of the panel discussions, witness tech demonstrations, and participate virtually in hybrid exhibitions to learn the most advanced and sophisticated skills from industry specialists. It is a great learning and marketing platform for newbies and reputed business firms alike where 2000 attendees, 150+ leading speakers, and 15+ exhibitors network, interact and discover new business avenues.

Some important topics include:

• Expert insights on achieving brand authenticity and transparency
• Tech keynotes
• Discussion of future retail trends and technologies over the next decade
• Retail online marketing transformation
• Changes in consumer behavior and preferences post-pandemic
• Marketing in the 2020 decade
• Traditional vs modern retail marketing
• Augmented reality for better shopping experiences
• Panel discussions on the emergence of private brands
• Immersive marketing strategies: case studies and discussions
• Leveraging the eCommerce boom
• Data management while ensuring consumer trust
• Inclusivity in workplace
• Decoding social, political, and economic consumer segmentation
• Scaling influencer marketing
• Decoding product discovery and consumer preferences
• Improving consumer experiences

At the DX3 Canada summit, keynote speakers will discuss relevant topics in digital marketing, retail, and new technological advances. In today’s world, as retail and technology go hand-in-hand, it’s critical that attendees learn the strategies and intricacies of eCommerce, digital marketing, and other tech-driven tools for their businesses, face-to-face from the experts.

The president and CEO, Hifazat ‘Faz’ Ahmad, has been focusing on expanding and growing business conference organizations across several continents. Connect and interact with industry leaders as they reveal their success stories on growth, advancement, and efficiency.

To learn more, please visit https://ibn.fm/m1loW.

• SideChannel recently released its financial results for Q1 2023, recognizing $1,546,000 in revenue, a 48% year-over-year increase
• The company also ended the fiscal quarter with $2,553,000 in cash, having spent about $480,000 to offset R&D and marketing expenses
• SideChannel is in the business of providing cybersecurity leadership and program development through its team of virtual Chief Information Security Officers (“vCISOs”)
• The company has also developed Enclave, a micro-segmentation software that recently received FIPS 140 certification, opening the door for SideChannel to pursue federal and state contracts and further increase cybersecurity revenue

SideChannel (OTCQB: SDCH), a company focused on delivering cybersecurity programs as a service and complimentary solutions to small and middle-market companies that have long been priced out of cybersecurity solutions, recently announced its financial results for the quarter ended December 31, 2022 (“Q1 2023”). The company recognized a 48% year-over-year revenue growth from $1,048,000 in Q1 2022 to $1,546,000 in the just-ended quarter (https://ibn.fm/ZQIlD). Furthermore, the Q1 2023 revenue represented a 26% quarter-over-quarter growth from Q4 2022 figures.

In addition, the company closed off the year with $2,553,000 in cash, having used about $480,000 in the just-ended quarter to offset operational expenses. More specifically, these expenses included investments in a few growth initiatives, including research and development (“R&D”) expenditure to advance its micro-segmentation software Enclave as well as sales and marketing to acquire new clients, according to SideChannel CFO Ryan Polk. Ryan was speaking in the company’s financial-results conference call hosted February 13. A recording of the call is available on the company’s website at https://ibn.fm/YxdC4 (registration required).

“An increasing number of emerging and mid-market companies are recognizing the need for more robust cybersecurity programs to reduce the risks impacting their business, whether it is from increased regulation, customer demands, or Board-level oversight,” CEO Brian Haugli conveyed in a news release announcing the financial results. “These companies turn to SideChannel to provide cybersecurity leadership and program development through our team of virtual Chief Information Security Officers (‘vCISOs’). In the last twelve months, revenue from our vCISO practice has increased 66%.”

The company intends to continue delivering on its strategy, which emphasizes growing vCISO relationships while adding complimentary products, cybersecurity services, and privacy services to help its clients cost-effectively reduce risk. SideChannel recognizes that small and middle-market companies face growing needs for cybersecurity through software and services. However, the rising costs and rapid turnover of Chief Information Security Officers (“CISOs”) leave them priced out of the market for the talent they truly need. In addition, CISOs are burning out and are looking for a better way to practice the profession they love and bring real value to companies in need of their services.

“We, as SideChannel, marry these two,” said Haugli in the conference call. “We offer cybersecurity programs as a service via senior experienced CISOs to those mid-market companies and emerging tech and startups on a fractional, cost-effective basis. This offers SideChannel’s customers unparalleled expertise and support, but at a price that is appropriate to their budgets. Moreover, they can also benefit from our expansive team, deep vertical expertise, and the opportunity to source from a wide array of software and other tools from across the industry.”

One software SideChannel’s clients can benefit from is Enclave. According to Haugli, this micro-segmentation application reduces risk, enhances productivity, and makes zero-trust a reality. “We can deploy Enclave in a variety of ways, either through direct license sales or via a managed service. And the focus shift on Enclave is not just to deliver encryption, but also deliver through micro-segmentation more than just encryption itself,” Haugli explained.

Enclave, Haugli intimated, is now a FIPS 140-certified product. (Federal Information Processing Standards or FIPS define the data security and computer system standards that an organization must heed. One of these standards, the FIPS 140, requires the system to have at least one working encryption algorithm https://ibn.fm/dg3tX. The certification clears SideChannel to pursue federal and state contracts, which require FIPS 140 compliance, and be able to sell Enclave to government entities. Thus, looking ahead, SideChannel is well positioned to grow revenue from cybersecurity software even further, considering that Q1 2023 revenue from this stream witnessed a 28% year-over-year growth, according to Ryan.

For more information, visit the company’s website at www.SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

• EverGen Infrastructure CEO, Chase Edgelow recently joined a webinar hosted by Adelaide Capital to provide investors and stakeholders with an update on the company’s operations
• Edgelow elaborated on the company’s portfolio, including its 4 existing revenue generating assets, 2 projects currently under construction as well as its Ontario-based Greenfield project, Project Radius
• By 2Q 2023, EverGen anticipated that the completion of its RNG projects would drive gross generating capacity to 240,000 GJ/annum, whilst growing EBITDA by $5-7m per year
• In the longer term, successful execution on EverGen’s Ontario-based Greenfield project could see the company expand its RNG production by as much as 1.7 million GJ/year

British-Columbia based natural gas operator, EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), has long held aspirations of transforming into Canada’s leading RNG infrastructure platform, in the process securing strong long-term contracted cash flows. The company today operates 4 revenue generating assets across 3 key regions in Canada, alongside 2 RNG projects currently under construction as well as one Ontario-based project in development. EverGen Infrastructure Corp CEO, Chase Edgelow recently participated in a webinar hosted by Adelaide Capital to provide investors with an update on the company’s ongoing operations as well as their prospects going forward (https://ibn.fm/XPI4q).

Edgelow revealed that following the completion of its two RNG projects currently under construction, namely Fraser Valley Biogas and GrowTEC, both of which are anticipated to be ready as of the end of Q1 2023–EverGen Infrastructure will see its built-up capacity expanded to 240,000 gigajoules of RNG per annum, a growth which could drive an additional $5-7 million dollars worth of EBITDA per year for the company. Meanwhile and on a longer-term basis, EverGen is simultaneously pursuing the expansion of all its ongoing projects through a broad-based $45m pre-funded capital expenditure plan; successful completion of all its initiatives will see the company grow its cumulative gross generating capacity to 480,000 gigajoules of renewable natural gas on an annual basis, whilst simultaneously tripling EverGen’s current run-rate EBITDA.

Over 37 billion tons of carbon emissions are released into the world’s atmosphere on a yearly basis (https://ibn.fm/uMUVl); in one recent study, BNY Mellon estimated that over $100 trillion in investments was necessary to tackle emissions if the world was to successfully achieve its stated Net Zero ambitions by 2050 (https://ibn.fm/XMRTj). Today and with over $1 trillion being invested annually into building out clean energy capacity (https://ibn.fm/0MS7Z), EverGen Infrastructure Corp finds itself operating at the center of what former Bank of England Governor, Mark Carney, referred to as the “greatest commercial opportunity of our age.”

EverGen Infrastructure’s path to becoming one of Canada’s largest RNG platforms owes its origins to the province of British Columbia’s decision in March 2017 to amend the Greenhouse Gas Reduction Regulation. The amendment, which sought to increase the production and use of renewable gas as well as green and waste hydrogen in British Columbia to simultaneously generate jobs and economic opportunities while reducing GHG emissions, has played a significant role in driving the sector’s growth prospects in recent years.

Since starting its operations and expanding its presence in British Columbia to three operating assets, EverGen Infrastructure made a bold decision to expand its presence nationwide over the past year. In 2022, the company broadened its Canadian footprint by acquiring a 67% stake in GrowTEC, an Alberta-based biogas project. EverGen would subsequently go on to purchase a 50% ownership in a large joint venture consisting of three high-quality, on-farm RNG projects in Ontario dubbed Project Radius.

It is within the latter Greenfield project that EverGen Infrastructure could stand to make its fortunes. Project Radius, located in southern Ontario, is a late-development-stage portfolio of three high-quality, on-farm RNG projects, collectively capable of producing ~1.7 million GJ/year of RNG that will contribute to the reduction of emissions from agricultural operations in southern Ontario. Each of the three projects is expected to produce ~550,000 GJ/year and will be constructed throughout 2023 and 2024.

“The acquisition of Project Radius provides a foothold in Ontario – a new and strategic jurisdiction in which EverGen can continue to participate in the consolidation and growth of the RNG industry in the near-term, as well as benefit from project economics in line with or exceeding those we have seen with our initial projects,” said Chase Edgelow, CEO of EverGen (https://ibn.fm/VBO5H). “Working alongside Northeast to advance the projects, EverGen will deliver on our platform expansion commitments with the potential to exceed 1,000,000 GJ of RNG production annually.”

For more information, visit the company’s website at www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF